These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23700881)

  • 1. Angiotensin converting enzyme inhibitors and pulmonary hypertension.
    Martiniuc C; Braniste A; Braniste T
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1016-20. PubMed ID: 23700881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enalapril treatment of residual pulmonary hypertension in patients operated rheumatic mitral valve defects].
    Privalova EV; Ershov VI; Ermakov AI; Ivanov AS; Baloian GM; Kulagina TI; Aksiuk MA; Dobrovol'skaia TN
    Klin Med (Mosk); 2000; 78(2):40-2. PubMed ID: 10723151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The comparison of the effect of enalapril and indapamide on the peripheral blood pressure and central blood pressure through pulse wave analysis].
    Jiang XJ; Li QY; Zhang YQ; Liu GZ; Liu LS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Oct; 33(10):885-8. PubMed ID: 16266472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of enalapril, an angiotensin-converting enzyme inhibitor, in pulmonary artery hypertension].
    Escudero J; Navarro J; Padua A; Betancourt L; Nava G
    Arch Inst Cardiol Mex; 1986; 56(6):467-73. PubMed ID: 3032121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between right ventricular indices and clinical improvement in epoprostenol treated pulmonary hypertension patients.
    Nath J; Demarco T; Hourigan L; Heidenreich PA; Foster E
    Echocardiography; 2005 May; 22(5):374-9. PubMed ID: 15901287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibition facilitates alveolar-capillary gas transfer and improves ventilation-perfusion coupling in patients with left ventricular dysfunction.
    Guazzi M; Melzi G; Marenzi GC; Agostoni P
    Clin Pharmacol Ther; 1999 Mar; 65(3):319-27. PubMed ID: 10096264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of cilazapril therapy on diastolic filling and left ventricular hypertrophy in patients with arterial hypertension].
    De Simone R; Irace L; Perna B; Caruso C; Guida M; Iacono A
    Minerva Cardioangiol; 1993 May; 41(5):205-9. PubMed ID: 8355860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypotension followed the first dose of angiotensin-converting enzyme inhibitor in patients with heart failure (a multicenter clinical trial)].
    Moiseev VS; Tereshchenko SN; Aleksandriia LG; Kobalava ZhD
    Ter Arkh; 2001; 73(9):61-6. PubMed ID: 11642085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinapril versus enalapril in the treatment of mild-to-moderate essential hypertension.
    Sánchez S; Luna A; Orozco R; Velasco G
    Clin Ther; 1991; 13(5):651-5. PubMed ID: 1799922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled nitric oxide plus iloprost in the setting of post-left assist device right heart dysfunction.
    Antoniou T; Prokakis C; Athanasopoulos G; Thanopoulos A; Rellia P; Zarkalis D; Kogerakis N; Koletsis EN; Bairaktaris A
    Ann Thorac Surg; 2012 Sep; 94(3):792-8. PubMed ID: 22727248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose response and safety of telmisartan in patients with mild to moderate hypertension.
    Smith DH; Matzek KM; Kempthorne-Rawson J
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1380-90. PubMed ID: 11185637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane.
    Guazzi M; Agostoni P
    Clin Sci (Lond); 1999 Jan; 96(1):17-22. PubMed ID: 9857102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
    Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D
    Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [24-Hour arterial pressure profile in chronic obstructive lung diseases in combination with arterial hypertension treated with enalapril].
    Ol'binskaia LI; Belov AA
    Ter Arkh; 2002; 74(3):59-62. PubMed ID: 11980126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and risk factors of asymptomatic first-dose hypotension with angiotensin-converting enzyme inhibitors in chronic heart failure due to systolic dysfunction.
    Thanikachalam S; Manchanda SC
    Indian Heart J; 2003; 55(2):167-71. PubMed ID: 12921333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Kumar A; Aronow WS; Vadnerkar A; Sivan K; Mittal S
    Am J Ther; 2009; 16(1):5-7. PubMed ID: 19142162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.